-
-
Extending the current grace period for reinjection of the contraceptive shot depot medroxyprogesterone acetate (DMPA, Depo-Provera, Pfizer) from two to four weeks does not increase pregnancy risk and could increase contraceptive continuation, indicate findings from a newly published study.
-
If your clinic is using oral fluid samples for rapid HIV testing, be sure to monitor for false-positive results.
-
Regulatory review of a second human papillomavirus (HPV) vaccine has been delayed. GlaxoSmithKline has announced plans to submit additional data from its large-scale clinical trial for its vaccine candidate, Cervarix.
-
Add a new resource on menopause management to your clinical practice. The North American Menopause Society (NAMS) has just updated its guidelines on postmenopausal hormone therapy.
-
-
The woman in your next examination room tells you she has a long-term partner who has multiple sexual contacts. While she says she is concerned about protection against HIV, she admits she cannot convince her partner to use a male condom. What is your next move?
-
If your practice includes care of those ages 45 and older, be prepared to discuss risk of sexually transmitted disease (STD) infection.
-
An estimated 182,460 new cases of invasive breast cancer, and approximately 40,930 breast cancer deaths (40,480 women, 450 men), are expected to occur among women in the United States during 2008.
-
